Pay in 4 interest-free payments of $6.56 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
We set the national incidence of the primary MACE endpoint over 54 months equal to that observed in the placebo arm of the SOUL trial (668 events among 4,825 participants, or 13.844%)
"I used to be clockwork regular
How a diabetes drug became a weight-loss hack, and why doctors are concerned The same drug that is helping patients manage diabetes and reduce their risk of serious complications from chronic conditions is also being discussed as a beauty hack by people hoping to lose a few kilograms
doi: 10.1007/s00520-019-05180-7 406
Hypoxia-inducible lipid droplet-associated (HILPDA) is a novel peroxisome proliferator-activated receptor (PPAR) target involved in hepatic triglyceride secretion
